Cargando…

Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial

Detalles Bibliográficos
Autores principales: Keohane, Denis, Schwartz, Jeffrey, Gundapaneni, Balarama, Stewart, Michelle, Amass, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642035/
http://dx.doi.org/10.1186/1750-1172-10-S1-P11
_version_ 1782400291248799744
author Keohane, Denis
Schwartz, Jeffrey
Gundapaneni, Balarama
Stewart, Michelle
Amass, Leslie
author_facet Keohane, Denis
Schwartz, Jeffrey
Gundapaneni, Balarama
Stewart, Michelle
Amass, Leslie
author_sort Keohane, Denis
collection PubMed
description
format Online
Article
Text
id pubmed-4642035
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46420352015-11-19 Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial Keohane, Denis Schwartz, Jeffrey Gundapaneni, Balarama Stewart, Michelle Amass, Leslie Orphanet J Rare Dis Poster Presentation BioMed Central 2015-11-02 /pmc/articles/PMC4642035/ http://dx.doi.org/10.1186/1750-1172-10-S1-P11 Text en Copyright © 2015 Keohane et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Keohane, Denis
Schwartz, Jeffrey
Gundapaneni, Balarama
Stewart, Michelle
Amass, Leslie
Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
title Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
title_full Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
title_fullStr Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
title_full_unstemmed Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
title_short Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
title_sort tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642035/
http://dx.doi.org/10.1186/1750-1172-10-S1-P11
work_keys_str_mv AT keohanedenis tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial
AT schwartzjeffrey tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial
AT gundapanenibalarama tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial
AT stewartmichelle tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial
AT amassleslie tafamidisreducesdiseaseprogressioninpatientswithtransthyretinfamilialamyloidpolyneuropathysupportiveposthocanalysesofapivotaltrial